
    
      The purpose of this study is to evaluate the effect of trelagliptin administered orally at a
      dose of 100 mg once weekly or alogliptin administered orally at a dose of 25 mg once daily
      for 4 weeks on glycemic variation in an exploratory manner as a primary objective and to
      evaluate the effect of difference method of administration of Dipeptidyl-peptidase (DPP)-4 on
      glycemic variation as secondary objective.
    
  